J. David Jentsch
J. David Jentsch is an American neuroscientist known for his research in the field of neuropsychopharmacology. He is a professor at the University of California, Los Angeles (UCLA) and has made significant contributions to understanding the biological basis of cognitive control and impulsivity.
Early Life and Education[edit | edit source]
Jentsch was born in the United States. He completed his undergraduate studies in psychology at Johns Hopkins University. He then pursued a Ph.D. in neuroscience at Yale University, where he conducted research on the neurochemical mechanisms underlying schizophrenia.
Research and Career[edit | edit source]
Jentsch's research primarily focuses on the neurobiological mechanisms of cognitive control, impulsivity, and addiction. His work has provided insights into how dopamine and other neurotransmitters influence these behaviors. He has published numerous articles in leading scientific journals and has been recognized with several awards for his contributions to the field.
At UCLA, Jentsch leads a research team that uses a combination of behavioral neuroscience, pharmacology, and genetics to study the brain mechanisms underlying complex behaviors. His research has implications for understanding and treating psychiatric disorders such as schizophrenia, bipolar disorder, and substance abuse.
Advocacy and Public Engagement[edit | edit source]
In addition to his research, Jentsch is an advocate for the ethical use of animals in scientific research. He has been involved in public outreach efforts to educate the public about the importance of animal research in advancing medical knowledge and treatments.
Awards and Honors[edit | edit source]
Jentsch has received several awards for his research, including the Society for Neuroscience's Young Investigator Award and the American College of Neuropsychopharmacology's Daniel H. Efron Research Award. He is also a fellow of the American Association for the Advancement of Science.
Selected Publications[edit | edit source]
- Jentsch, J. D., & Taylor, J. R. (1999). Impaired reversal learning in rats with neurotoxic lesions of the dorsomedial striatum. Behavioral Neuroscience, 113(3), 420-432.
- Jentsch, J. D., & Roth, R. H. (2000). The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 22(2), 201-225.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD